Celestial StormCelestial Storm🃏All Oricorio cards
Ask about Oricorio
Oricorio #30 Pokémon card from Celestial Storm

Oricorio 30/168

Celestial Storm

Find this card on eBay

Affiliate link · we may earn commission

Oricorio #30 from Celestial Storm currently trades at $0.69 raw, with PSA 10 copies reaching $32.99 — a 47.8x grade premium.
Current Prices (USD)
Ungraded
$0.69
PSA 7
$11.77
PSA 8
$11.77
PSA 9
$11.77
PSA 10
$32.99
ACE 10
BGS 10 Black
$215.00
CGC 10 Pristine
$36.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Oricorio 30/168 from Celestial Storm has a current raw market value of $0.69.

Current raw value
$0.69
PSA 9 value
$11.77
PSA 10 value
$32.99
PSA 10 premium vs raw
47.8× raw
View all cards from Celestial Storm
Collector Intel
47.8x
Raw → PSA 10
High-risk grade
17.1x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 48x the raw price. The expected value accounts for the realistic probability.
$1
Buy Raw
~$25
Grading Fee
PSA Standard
$33
PSA 10 Value
+$7
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$1217.1x raw
PSA 10$3347.8x raw

Frequently asked questions

How much is Oricorio #30 from Celestial Storm worth?+
Oricorio #30 from Celestial Storm is currently worth Raw: $0.69, PSA 9: $11.77, PSA 10: $32.99 based on recent sold listings. Prices update daily from real eBay sales.
Is Oricorio #30 worth grading?+
The PSA 10 price of $32.99 is 47.8× the raw price of $0.69. After a ~$25 grading fee, a PSA 10 result would net approximately $32.30 — assuming the card grades a 10.
Where do PokePrices Oricorio #30 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.